Computational Health Center

The application of artificial intelligence methods for the generation of antimicrobial peptides will be the subject of research in the Deep Optimised Generation of AntiMicrobial Peptide (DOG-AMP) project. The project will be carried out by Prof. Ewa…

The first "Munich for Women in Science" event is dedicated to inspiring positive change for Women in Science. The event will be hosted by Helmholtz Munich and has been organized in collaboration with the Technical University Munich (TUM), the…

What the Human Cell Atlas (HCA) will tell us about ourselves and how scientists at Helmholtz Munich are facilitating this revolutionizing global endeavor.

The European Research Council (ERC) today awarded 37 particularly well-funded Synergy Grants across Europe. One of these interdisciplinary research awards went to Julien Gagneur, Group Leader at Helmholtz Munich and Professor of Computational…

Artificial Intelligence (AI) is becoming increasingly crucial in medical research, and Helmholtz Munich is one of the world's leading institutions in this field. It can detect tumors as effectively as severe eye diseases.

The AiChemist project has officially started in September 2023 Coordinated by Helmholtz Munich the project is an Innovative Doctoral Training Network funded with 3 million euros provided by the Marie Skłodowska-Curie Actions (MSCA-DN) within the EU…

ScPoli Enables Multi-Scale Representations of Cells and Samples

The increasing amount of data recorded in medical research can only lead to scientific breakthroughs and essential therapies for patients if interpreted and analyzed correctly.…

Researchers at Helmholtz Munich and the Technical University of Munich have made significant progress in advancing high-resolution optoacoustic imaging for clinical use. Their innovative deep-learning framework, known as DeepMB, holds great promise…

A collaborative endeavor between computer scientists and diabetes researchers at Helmholtz Munich has yielded novel insights into the mechanisms underlying type 1 and type 2 diabetes. This collaboration has resulted in the creation of the first mouse…

Helmholtz Munich and the Eric and Wendy Schmidt Center at the Broad Institute launch Collaborative Research Initiative

Helmholtz Munich and the Eric and Wendy Schmidt Center at the Broad Institute of MIT and Harvard announced the launch of a…

Dr. Michael Zech received the David Marsden Award 2023 from Dystonia Europe at the 9th EAN Congress in Budapest, Hungary. The award recognizes his groundbreaking research on the genetics of movement disorders, particularly dystonia.

Prof. Fabian Theis, the AI expert, Director of the Computational Health Center at Helmholtz Munich, and Coordinator of Helmholtz AI takes on another important role for AI-based medical research: As Director for Biomedical AI, he complements the…

The International Society for Computational Biology (ISCB) annually recognizes exceptional individuals in the fields of computational biology and bioinformatics through its prestigious Fellows program. This year, Prof. Fabian Theis, Head of the…

Can a human organ be mapped on a single-cell level to learn about the functionality of each individual cell? And can we learn how different these cells are from person to person? Helmholtz Munich researchers and their collaborators have taken up this…

A new ad hoc working group with the topic of “artificial intelligence in medicine” started at the Bavarian Academy of Sciences and Humanities (BAdW). The project is planned for three years and will be executed by the Bavarian Academy of Sciences and…

Analysis of genes can help in detecting diseases at an early stage as well as in determining new drug targets for therapy. Thanks to extremely powerful data processing, the field holds great promise for advancement. Helmholtz Munich is particularly…

The German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) awarded Fabian Theis the Gottfried Wilhelm Leibniz Prize – the most prestigious research award in Germany. Fabian Theis is Head of the Computational Health Center at Helmholtz…

In the future, blood samples from patients can be evaluated not only by specialists, but also by artificial intelligence. A team from Helmholtz Munich is laying the foundations for this.

Mohammad Lotfollahi wins the prestigious Bayer Foundation "Early Excellence in Science Award" in the category "Data Sciences" in Life Sciences for his pioneering machine learning algorithms.

Blood Bots

By leveraging the power of AI, computers can detect leukemia in blood samples – with accuracy to match their human counterparts